pTXRE5-Z
(Plasmid
#112509)
-
PurposeReporter plasmid, responsive to activated Ah receptor/Arnt
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 112509 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backboneunknown
-
Vector typeYeast Expression
-
Selectable markersTRP1
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameRW95-3 with 5x xenobiotic response elements
-
Alt nameDRE
-
Alt nameLacZ
-
SpeciesSynthetic; E.coli
-
Entrez GenelacZ (a.k.a. b0344, ECK0341)
- Promoter 5 XREs+ minimal Cytochrome C
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site unknown (unknown if destroyed)
- 3′ cloning site unknown (unknown if destroyed)
- 5′ sequencing primer M13 Reverse (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Addgene NGS found that the LacZ translation lacks the last C-terminal 11 amino acids compared to NCBI reference sequence AAB49976.1. The depositing laboratory states that this difference does not adversely affect protein function
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pTXRE5-Z was a gift from Charles Miller (Addgene plasmid # 112509 ; http://n2t.net/addgene:112509 ; RRID:Addgene_112509) -
For your References section:
A human aryl hydrocarbon receptor signaling pathway constructed in yeast displays additive responses to ligand mixtures. Miller CA 3rd. Toxicol Appl Pharmacol. 1999 Nov 1;160(3):297-303. doi: 10.1006/taap.1999.8769. 10.1006/taap.1999.8769 PubMed 10544064